SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-468948
Filing Date
2012-11-14
Accepted
2012-11-14 07:15:53
Documents
3
Period of Report
2012-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d438968d8k.htm 8-K 14432
2 PRESS RELEASE d438968dex991.htm EX-99.1 73815
3 GRAPHIC g4389681.jpg GRAPHIC 2925
  Complete submission text file 0001193125-12-468948.txt   93561
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-177498 | Film No.: 121200974
SIC: 2834 Pharmaceutical Preparations